Characterisation of Non-P-Glycoprotein multidrug-resistant Ehrlich ascites tumour cells selected for resistance to mitoxantrone
- 1 August 2000
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 60 (3) , 363-370
- https://doi.org/10.1016/s0006-2952(00)00337-3
Abstract
No abstract availableKeywords
Funding Information
- Novo Nordisk Fonden
- Kræftens Bekæmpelse (93-013)
This publication has 27 references indexed in Scilit:
- Major vault protein LRP-related multidrug resistanceEuropean Journal Of Cancer, 1996
- Mechanisms of resistance to topoisomerases poisonsGeneral Pharmacology: The Vascular System, 1995
- Cellular Resistance to Cancer ChemotherapyPublished by Elsevier ,1994
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- Catalytic function of DNA topoisomerase IIBioEssays, 1991
- MitoxantroneDrugs, 1991
- Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26Biochemistry, 1988
- Inter-experiment variation and dependence on culture conditions in assaying the chemosensitivity of human small cell lung cancer cell linesEuropean Journal of Cancer and Clinical Oncology, 1987
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984
- Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cellsBiochemical Pharmacology, 1978